A model to estimate the cost benefit of an occupational vaccination programme for influenza with Influvac® in the UK

PharmacoEconomics

Volumn 20, Issue 7, 2002, Pages 475-484

  Das Gupta, Roben ^a   Guest, Julian F ^a  

^a CATALYST Health Economics Consultants   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ABSENTEEISM; ARTICLE; COCHRANE LIBRARY; COST BENEFIT ANALYSIS; ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; INCIDENCE; INFLUENZA; INFLUENZA VACCINATION; MEDLINE; PRIORITY JOURNAL; PRODUCTIVITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; UNITED KINGDOM; VACCINATION;

EID: 0036075928     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200220070-00005     Document Type: Article

References (38)

1. Advances in influenza virus vaccine research
2. The contribution of influenza to combined acute respiratory infections, hospital admissions and deaths in winter
3. Deaths in Great Britain associated with influenza epidemic of 1989/90: Population trends
4. French economic evaluations of influenza and influenza vaccination
5. Influenza: The role of burden-of-illness research
6. Economic evaluation of influenza vaccination: Assessment for the Netherlands
7. Evaluating the impact of influenza vaccination: A North American perspective
8. Community-acquired lower respiratory tract infections: The annual cost to the National Health Service
9. The efficacy of influenza vaccination in elderly individuals: A randomised double-blind placebo controlled trial
10. The efficacy of influenza vaccination in elderly persons: A meta-analysis and review of the literature
11. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
12. Influenza vaccination in 29 countries: An update to 1997
13. Influenza immunisation
14. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989/90 using a general practice database
15. The efficacy and cost effectiveness of vaccination against influenza among elderly people living in the community
16. Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, the Netherlands
17. Cost-effectiveness of the influenza vaccine in a healthy, working age population
18. The population at risk in relation to influenza immunisation policy in England and Wales
19. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomised controlled trial
20. Influenza vaccination among healthy employees: A cost-benefit analysis
21. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population
22. Vaccines for preventing influenza in healthy adults
23. Cost benefit analysis
24. Diagnosis and patterns of incidence of influenza, influenza-like illness and the common cold in general practice
25. Health impact of influenza in the United States
26. Serious morbidity and mortality associated with influenza epidemics
27. Effectiveness of influenza vaccine in healthcare professionals. A randomised trial
28. Indirect costs in economic studies: Confronting the confusion
29. The effectiveness of vaccination against influenza in healthy, working adults
30. Cost-effectiveness of the influenza vaccine in a healthy, working-age population
31. French economic evaluations of influenza and influenza vaccination
32. Economic impact of providing workplace influenza vaccination: A model and case study application at a Brazilian pharma-chemical company
33. Effectiveness and cost-benefit of an influenza vaccination program for healthcare workers